Balance Sheet for Leap Therapeutics Inc. (LPTX)

$ 0.80   0.001865 (+0.23%) Volume: 41.68k 12:54 PM EST 10-Dec-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 16,284 25,737 793 405 10,868
Restrictable Cash - - - - -
Marketable Securities - - - 6,607 35,313
Accounts Receivable 836 1,744 3,053 - 379
Loans Receivable - - - - -
Other Receivables 836 1,744 - - -
Receivables 836 1,744 3,053 - 379
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 202 177 183 89 157
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 17,322 27,658 4,029 494 46,717
Land and Improvements - - - - -
Buildings and Improvement 69 69 69 219 321
Machinery, Furniture and Equipment 139 139 75 511 663
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 208 208 144 730 984
Gross Fixed Assets 208 208 144 730 984
Accumulated Depreciation (122) (73) (25) (498) (533)
Net Fixed Assets 86 135 119 232 451
Intangibles - - - 138 276
Cost in Excess - - - - -
Non-Current Deferred Income Taxes 124 158 - - -
Other Non-Current Assets 1,542 1,111 907 - 1,255
Total Non-Current Assets 1,752 1,404 2,428 766 1,982
Total Assets 19,074 29,062 6,457 1,260 48,699
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 3,579 2,622 3,225 2,048 134
Short Term Debt - - 30,274 3,141 -
Notes Payable - - - - -
Accrued Expenses 2,872 3,461 2,633 479 1,509
Accrued Liabilities 2,872 3,461 2,633 479 1,509
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - 25 - 845
Total Current Liabilities 6,451 6,083 36,157 5,668 2,488
Long Term Debt - - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities 3,448 11,862 - - -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - 70,531 65,881 -
Total Non-Current Liabilities 3,448 11,862 70,531 65,881 -
Total Liabilities 9,899 17,945 106,688 71,549 2,488
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 9,175 11,117 (100,231) (70,289) 46,211
Common Par 15 12 - - 45
Additional Paid in Capital 162,393 141,770 145 100 102,108
Cumulative Translation Adjustments - - - - -
Retained Earnings (153,535) (130,397) (100,670) (70,388) (68,198)
Treasury Stock - - - - -
Other Equity Adjustments 302 (268) 294 (1) 16,114
Total Capitalization 9,175 11,117 (100,231) (70,289) 46,211
Total Equity 9,175 11,117 (100,231) (70,289) 46,211
Total Liabilities & Shareholder's Equity 19,074 29,062 6,457 1,260 48,699
Cash Flow (23,138) (29,971) (25,632) (21,103) (25,451)
Working Capital 10,871 21,575 (32,128) (5,174) 44,229
Free Cash Flow (26,033) (22,201) (25,481) (19,592) (18,244)
Invested Capital 9,175 11,117 (100,231) (70,289) 46,211
Shares Outstanding - Common Class Only 14,703 12,354 17,081 17,058 16,262
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 14,703 12,354 17,058 17,058 16,262
Total Common Shares Outstanding 14,703 12,354 17,081 17,058 16,262
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 14,144 9,162 9,392 18,248 11,863
Diluted Weighted Shares Outstanding 14,413 9,189 9,392 18,248 11,863